Search Results Search Sort by RelevanceMost Recent Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557. Case and Commentary Sep 2021 What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care? Jeffrey Bedard, MS Lack of training and lack of knowledge can adversely influence a patient’s clinical outcomes. AMA J Ethics. 2021;23(9):E692-696. doi: 10.1001/amajethics.2021.692. Podcast Sep 2021 Author Interview: What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care? Jeffrey Bedard joins Ethics Talk to discuss his article: "What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care?" AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Case and Commentary Sep 2020 How Should Clinicians’ Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences? Safiya Richardson, MD, MPH Interventions’ influences on decision making situate clinician performance evaluations in key ways. AMA J Ethics. 2020;22(9):E760-766. doi: 10.1001/amajethics.2020.760. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Medical Education Aug 2016 Improving Pathologists’ Communication Skills Suzanne Dintzis, MD, PhD The communication training program at University of Washington Medical Center aims to develop best practices for effective pathology communication. AMA J Ethics. 2016;18(8):802-808. doi: 10.1001/journalofethics.2016.18.8.medu1-1608. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Jul 2019 When There’s No One to Whom an Error Can Be Disclosed, How Should an Error Be Handled? Ryan G. Chiu When a patient is incompetent and unrepresented, alternative strategies must be implemented to document and try to rectify an error. AMA J Ethics. 2019;21(7):E553-558. doi: 10.1001/amajethics.2019.553. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557.
Case and Commentary Sep 2021 What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care? Jeffrey Bedard, MS Lack of training and lack of knowledge can adversely influence a patient’s clinical outcomes. AMA J Ethics. 2021;23(9):E692-696. doi: 10.1001/amajethics.2021.692.
Podcast Sep 2021 Author Interview: What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care? Jeffrey Bedard joins Ethics Talk to discuss his article: "What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care?"
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Case and Commentary Sep 2020 How Should Clinicians’ Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences? Safiya Richardson, MD, MPH Interventions’ influences on decision making situate clinician performance evaluations in key ways. AMA J Ethics. 2020;22(9):E760-766. doi: 10.1001/amajethics.2020.760.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Medical Education Aug 2016 Improving Pathologists’ Communication Skills Suzanne Dintzis, MD, PhD The communication training program at University of Washington Medical Center aims to develop best practices for effective pathology communication. AMA J Ethics. 2016;18(8):802-808. doi: 10.1001/journalofethics.2016.18.8.medu1-1608.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Jul 2019 When There’s No One to Whom an Error Can Be Disclosed, How Should an Error Be Handled? Ryan G. Chiu When a patient is incompetent and unrepresented, alternative strategies must be implemented to document and try to rectify an error. AMA J Ethics. 2019;21(7):E553-558. doi: 10.1001/amajethics.2019.553.